making medicine

If a Medicine Is Too Expensive, Should a Hospital Make Its Own?

Chris Stokel-Walker

The price increase soon had an effect. The Netherlands has an insurance-based health system, and in April 2018, Dutch insurers – who had been paying for 50 or so patients across the country to receive the drug – balked at the fivefold increase, refusing to pay. Patients unable to pay themselves would have gone without treatment, so Kemper – whose hospital was one of the treatment centers for CTX – stepped in.

Subscribe to RSS - making medicine